News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
Views & Analysis Five tech companies advancing against cancer New cancer tech devices for oncology screening, diagnosis and mental wellbeing.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
News Seattle, Takeda aim for first line Adcetris use Seattle CEO hopes Adcetris will be standard of care.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
